Serge Weinberg and Antoine Yver
Sanofi signals a big interest in oncology as it adds a cancer R&D star to the board
It’s not common for Big Pharma to put the CMO of a small biotech company on the board. But that’s exactly what Sanofi chairman Serge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
